Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tests faster abortion method for women with scarred uterus

NCT ID NCT07465016

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compared two approaches for inducing abortion in the second trimester for women who have a scarred uterus (e.g., from a previous C-section). One group received a laminaria tent (a seaweed rod that gently opens the cervix) for 12 hours followed by misoprostol pills, while the other group received misoprostol alone. The main goal was to see which method led to a shorter time from start to completion of abortion. The trial included 60 women aged 18-45 with a pregnancy between 13-26 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Misoprostol and Laminaria japonicum
What this could lead to
If successful, this could show that using a laminaria tent before misoprostol shortens the time needed for abortion in women with a scarred uterus.
What could go wrong
This is a small, completed Phase 4 trial with only 60 participants, so results may not apply to all women. Risks include bleeding, uterine rupture, or need for surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

60 people

The number who actually took part.

Started

Jan 2023

Finished

Jan 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age range 18-45 years old. * Women with previous scarred uterus. * Presence of an indication for induction of abortion. * Estimated gestational age between 13-26 weeks as calculated from last normal menstrual period (LMP) and confirmed by abdominal ultrasound. Exclusion Criteria: * Primigravida women. * Pregnant women with placenta previa accreta spectrum. * Women with diagnosed cervical cancer. * History of cervical surgery or presence of cervical scarring. * Presence of allergy to any of the used drugs in the study. * Women withdraws or declines to participate in this study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Induction of abortion are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ain Shams Maternity Hospital

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.